The downgrade reflects CAMC’s recent weaker operating performance, slowed revenue growth and significant reliance on state supplemental funding to support its operations.
The negative outlook is based on Moody’s Investors Service’s expectation that CAMC’s operations and liquidity will remain pressured.
More articles on healthcare finance:
14 recent hospital outlook and credit rating actions
Moody’s downgrades Fremont-Rideout Health’s rating to ‘B1’
S&P revises Flagler Hospital’s outlook to negative
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
